Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cleary

Showing results (401-410 of 445) with videos related to

Pageof 45
Sort By:
Journal for Immunotherapy of Cancer|October 1, 2021
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survivalLeonie K de Klerk, Anuj K Patel, Sarah Derks, et al.
The Lancet. Oncology|May 17, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2021
Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i>-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i>-Mutated TumorsJames M Cleary, Victoria Wang, Rebecca S Heist, et al.
JAMA|April 10, 2019
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical TrialKimmie Ng, Halla S Nimeiri, Nadine J McCleary, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trialsT Yoshino, J M Cleary, E Van Cutsem, et al.
Forest Ecology and Management|May 16, 2023
The increasing threat to European forests from the invasive foliar pine pathogen, <i>Lecanosticta acicola</i>K Tubby, K Adamčikova, K Adamson, et al.
Molecular Genetics and Metabolism|October 27, 2015
The challenges of managing coexistent disorders with phenylketonuria: 30 casesA MacDonald, K Ahring, M F Almeida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Cancers|November 25, 2020
Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized TrialJustin C Brown, Michael H Rosenthal, Chao Ma, et al.
Science (New York, N.Y.)|May 8, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognitionZackery A Ely, Zachary J Kulstad, Gurcan Gunaydin, et al.
Pageof 45

Showing results (401-410 of 445) with videos related to

Sort By:
Pageof 45
Journal for Immunotherapy of Cancer|October 1, 2021
Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survivalLeonie K de Klerk, Anuj K Patel, Sarah Derks, et al.
The Lancet. Oncology|May 17, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2021
Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i>-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i>-Mutated TumorsJames M Cleary, Victoria Wang, Rebecca S Heist, et al.
JAMA|April 10, 2019
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical TrialKimmie Ng, Halla S Nimeiri, Nadine J McCleary, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trialsT Yoshino, J M Cleary, E Van Cutsem, et al.
Forest Ecology and Management|May 16, 2023
The increasing threat to European forests from the invasive foliar pine pathogen, <i>Lecanosticta acicola</i>K Tubby, K Adamčikova, K Adamson, et al.
Molecular Genetics and Metabolism|October 27, 2015
The challenges of managing coexistent disorders with phenylketonuria: 30 casesA MacDonald, K Ahring, M F Almeida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Cancers|November 25, 2020
Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized TrialJustin C Brown, Michael H Rosenthal, Chao Ma, et al.
Science (New York, N.Y.)|May 8, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognitionZackery A Ely, Zachary J Kulstad, Gurcan Gunaydin, et al.
Pageof 45